Need a response to the following: 
Therapy guidelines for H. Pylori Treatment
H. Pylori remains to be one of the most common chronic bacterial infection affecting humans. Research shows that H. Pylori is normally acquired during childhood, with most victims being those who are socially disadvantaged and people who have migrated to North America (Chey et al., 2017). Although currently, there are no new drugs that have been developed, treatment primarily depends on a mixture of antibiotics and anti-secretory agents. H. Pylori treatment regimens are such as triple therapy, sequential therapy, quadruple treatment, and levofloxacin-based triple therapy (De Francesco et al., 2017). In selecting the best treatment regimen, it’s important to consider previous antibiotic exposure, the rate of eradication, and regional antibiotic-resistance patterns as these can affect the successful treatment of the condition (Myran & Zarbock, 2018). Additionally, it can be noted that for a treatment to be effective and successful, then host factors such as allergies and patient adherence need to be considered (Fashner & Gitu, 2015).
           Recent treatment guidelines have recommended quadruple therapy, which consists of PPI and three antibiotics (metronidazole, clarithromycin, and amoxicillin), which are to be administered concurrently (Chey et al., 2017). According to Shiotani et al. (2017), the rationale for this treatment option is that it’s not evidence-based but “hope-based” because gastroenterologists do believe that the infection would be susceptible to metronidazole or clarithromycin. 
           Patient compliance is a key factor that would determine treatment success. To minimize cases of side effects, clinicians should talk to their patients to adhere to their treatment plans and also instruct their patients on the right time to take their doses in relation to their meal (Li et al., 2019). Patients should be informed that they should avoid taking alcohol with metronidazole, avoid cheese, soy beans, and soy sauce taken with furazolidone (Li et al., 2019). Finally, it’s important to advice the patient to maintain personal hygiene by taking clean water and avoid ingesting contaminated food.
The original work is below in case you needed:
GI Case Study:
Chief complaint: “I have recurrent H. Pylori infection”. 
HPI: M.C. a 46-year-old Hispanic female presents to the GI clinic for complaint of recurrent H. Pylori infection. She was treated about 2 ½ months ago with H. Pylori triple therapy and failed treatment. She has PMH of dyspepsia, and GERD. She also indicates that she has noticed that her symptoms of dyspepsia are worsening for past 2 months. She has associated her symptoms with nausea, upset stomach with all foods. Denies associated symptoms of hematochezia, melena, hemoptysis, abdominal pain, fever, chills, pain or any other symptoms. 
PMH: 
H. Pylori infection gastritis
Diabetes Mellitus, type 2
Surgeries: None
Allergies: NKDA
Vaccination History: Up-to-date
Social history:
High school graduate, married and no children. He frequently eats out in restaurants. He drinks one 4-ounce glass of red wine daily. He is a former smoker that stopped 3 years ago.
Family history:
Both parents are alive. Father has history of DM type 2, Tinea Pedis. Mother alive and has history of atopic dermatitis, tinea corporis and tinea pedis. 
ROS:
Constitutional: Negative for fever. Negative for chills. 
Respiratory: No Shortness of breath. No Orthopnea. 
Cardiovascular: No edema. No palpitations. 
Gastrointestinal: No vomiting. +Dyspepsia. + Nausea. No constipation. No melena. No abdominal pain.
Physical examination:
Vital Signs
Height: 5 feet 5 inches Weight: 140 pounds BMI: 31 obesity, BP 110/70 T 98.0 po P 80 R 22, non-labored
ABDOMEN: No abdominal distention. Nontender. Bowel sounds + x 4 quadrants. No organomegaly. Normal contour; No palpable masses.
Labs day of visit:: Hgb 15.2, Hct 40%, K+ 4.0, Na+137, Serum Creatinine normal 1.0, AST/ALT normal. TSH 3.7 normal, glucose 98 normal
Assessment:
Primary Diagnosis: Recurrent H. Pylori infection gastritis
Secondary Diagnoses: Dyspepsia
Differential Diagnosis: Peptic Ulcer Disease
Previous medication plan: two months ago and failed. Clarithromycin      500 mg po BID for 2 weeks Omeprazole      40 mg po BID for 2 weeks and then po daily. Cipro      500 mg po BID for 2 weeks
Plan: Tests
Pt had EGD done 2 weeks ago that showed H. Pylori positive gastritis in biopsy results. 
Urea breath test 8 weeks after treatment with H. Pylori medications. Pt needs to stop PPI’s 2 weeks prior to Urea Breath test. 
Labs: No new labs are needed.  
Referrals: may refer based on effect of medication therapy given for 2 weeks.
Follow up: return to office in 8 weeks to reevaluate symptoms.
As a future nurse practitioner, it is important that you determine the medications used for recurrent H. Pylori infection. 
Please discuss new therapy guidelines for H. Pylori treatment, and provide patient education.

Briefly explain why some might view Dissociative Identity Disorder (DID) as an extreme subcategory of PTSD (Post Traumatic Stress Disorder)
Reference
Comer, R. (2015). Abnormal Psychology, Ninth Edition. Worth Publishers; New York, New York. (ISBN 978-1-4641-7170-3)
American Psychiatric Association (2013). Diagnostic and statistical manual for mental disorders, (5th Ed.). American Psychiatric Publishing, Inc.; Washington, DC.

 
 
Equal Employment Opportunity and Workforce Analysis
 
Review HR Management text book regarding equal pay/pay equity. As it relates to employee and labor relations, why is it necessary for HR professionals to understand the importance of this concept? What can be done to mitigate risks associated with unfair pay?
 
How might job analysis and wage/hour regulations discussed in Chapter 4 affect employee or labor relations? Be sure to highlight things like overtime pay, safety, and staffing.
 
Here are the details for Order
 
http://www.24activ.com/tickets/scp/public_attachment.php?id=2df12
http://www.24activ.com/tickets/scp/public_attachment.php?id=2df13
 
2 pages, 4 APA
 

Refer to Problem 4.2. Develop a forecast for years 2 through 12 using exponential smoothing with α= .4 and a forecast for year 1 of 6. Plot your new forecast on a graph with the actual data and the naive forecast. Based on a visual inspection, which forecast is better?
Problem 4.2
a) Plot the above data on a graph. Do you observe any trend, cycles, or random variations?
b) Starting in year 4 and going to year 12, forecast demand using a 3-year moving average. Plot your forecast on the same graph as the original data.
c) Starting in year 4 and going to year 12, forecast demand using a 3-year moving average with weights of .1, .3, and .6, using .6 for the most recent year. Plot this forecast on the same graph.
d) As you compare forecasts with the original data, which seems to give the better results?
 

  Class, In lieu of the Simulation that was originally planned for this Friday, February 28, 2020, I am asking you to complete a total of 1 case study. Here is what you need to do after reading *each* scenario:
1) Complete an SBAR for each patient/scenario as if you were going to be calling the provider for the patient 2) ADPIE the patient/scenario. Write this out in detail and include constructs such as subjective and objective data 3) Demonstrate the priority of care including what you would do first, second, etc. and why you would do that 4) Create a detailed concept map of your choice on the patient/scenario 5) Answer, in detail, the questions asked on each case study 6) Name 1-3 things you learned completing this case study and 1-3 areas of knowledge you have that helped you complete this case study. Approx. the estimated time frame for this case study is about 3.45 hours which is the remaining clinical hours for this class. 
Note: submit them in APA format  include in Text citationcase study 6.pdf 
Send